🚀 High Value: #Litecoin ( $LTC ) and MEI Pharma (MEIP) - July 2025

🔥 Litecoin (LTC): Opportunity with Unique Catalysts

- Current Price: $100 (+12% weekly)

- Bullish Keys:

✅ MEI Pharma bought $100M in LTC (1st public holding to adopt it)

✅ Spot ETF under evaluation by the SEC (decision Q4 2025)

✅ Halving 2023: Delayed effect on price (target $150-$200)

- Supports/Risks:

- 🟢 $91.87 (institutional support)

- 🔴 Correction if BTC loses $100K

💊 MEI Pharma (MEIP): Radical Reinvention with Crypto

- Historic Change: From biotechnology to crypto company (LTC as reserve)

- Stock (NASDAQ): $5.92 (+31% in 24h)

- 📉 Annual range: $1.46-$9 (high volatility)

- 💰 $23.7M in cash + $100M to buy LTC

- Key Risks:

- SEC could block its crypto strategy

- Total dependence on LTC performance

🔗 Key Connection: Charlie Lee (LTC) on MEI Pharma Board

- Strategic synergy: MEIP = crypto Tesla of 2025

💡 Opportunities and Alerts

- For Investors:

- LTC: Buy on pullbacks at $95-$98 (stop-loss $90)

- MEIP: Only for HIGH-RISK profiles (possible x2 or bankruptcy)

- Trading:

- LTC broke bullish triangle (target $130)

- MEIP with record volume (2.5M shares vs. average 500K)

⚠️ Warning: LTC/MEIP are volatile assets. Diversify and use only capital you can afford to lose.

📆 Upcoming Catalysts:

- July 25: MEI Pharma quarterly report

- August: Possible LTC ETF update